Close
Help




JOURNAL

Clinical Medicine Insights: Case Reports

Double Hit Lymphoma – a Case of Unusual Response After Sequential Aggressive Chemotherapy and Review of the Literature

Submit a Paper


Clinical Medicine Insights: Case Reports 2014:7 117-121

Case report

Published on 01 Oct 2014

DOI: 10.4137/CCRep.S11393


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Case Reports

Abstract

Lymphomas with recurrent chromosomal breakpoints activating multiple oncogenes, including MYC, BCL2, and BCL6 are often referred to as “Dual Hit” or “Double Hit” lymphomas (DHL). In the updated classification for malignant lymphomas by the World Health Organization (WHO), the novel category of “B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphoma (BL)” was proposed in an attempt to create a (temporary) container for aggressive mature B-cell lymphomas that should not be diagnosed as either BL or DLBCL. DHL make up an important part of this novel WHO category, the other part representing heterogeneous cases of aggressive B-cell lymphoma that have features of BL. DHL are highly aggressive lymphomas with generally poor response to first line and salvage treatment. Limited data is available to guide therapeutic decisions, and despite aggressive measures including high dose (HD) chemotherapy followed by autologous hematopoietic cell transplantation (AHCT), outcome is unsatisfyingly poor. Herein, we report a case of a patient with DHL and review the relevant literature.



Downloads

PDF  (684.86 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Case Reports
My experience of publishing my article with Libertas Academia was excellent. They professionally handled the review process. The quality of the reviews were high. I look forward to publishing my scientific papers again with Libertas Academia.
Dr Assy Nimmer (Ziv Medical Center, Safed, Israel)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube